Company news

HLS Therapeutics, Inc. news in 2026

HLS Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

HLS Therapeutics Partners with Bayer to Commercialize VERQUVO® in Canada

November 3, 2026

HLS Therapeutics to Host Q3 2026 Financial Results Conference Call

October 29, 2026

HLS Therapeutics to Present at the Planet MicroCap Toronto Conference

October 27, 2026

Investor Presentation Fall 2026

October 2, 2026

HLS Therapeutics Announces Board of Directors Changes

October 1, 2026

HLS Therapeutics Increases Normal Course Issuer Bid

September 24, 2026

HLS Therapeutics Announces Q2 2026 Financial Results

August 12, 2026

HLS Therapeutics Provides Update on NILEMDO™ Market Access

August 5, 2026

HLS Therapeutics to Host Q2 2026 Financial Results Conference Call

July 29, 2026

HLS Therapeutics Announces Q1 2026 Financial Results

May 15, 2026

HLS Therapeutics to Host Q1 2026 Financial Results Conference Call

May 1, 2026

HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

April 14, 2026

HLS Therapeutics Announces Fiscal 2025 Financial Results

March 12, 2026

HLS Therapeutics Announces NILEMDOTM (bempedoic acid) is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease

March 5, 2026

HLS Therapeutics to Host Fiscal 2025 Financial Results Conference Call

February 26, 2026

Calls in 2026

Decks in 2026